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While we have considerable understanding of the
transcriptional networks controlling mammalian cell
differentiation, our knowledge of posttranscriptional
regulatory events is very limited. Using differentiation
of primary erythroid cells as a model, we show
that the sequence-specific mRNA-binding protein
Cpeb4 is strongly induced by the erythroid-important
transcription factors Gata1 and Tal1 and is essential
for terminal erythropoiesis. By interacting with the
translation initiation factor eIF3, Cpeb4 represses
the translation of a large set of mRNAs, including
its own mRNA. Thus, transcriptional induction and
translational repression combine to form a negative
feedback loop to control Cpeb4 protein levels within
a specific range that is required for terminal eryth-
ropoiesis. Our study provides an example of how
translational control is integrated with transcriptional
regulation to precisely control gene expression dur-
ing mammalian cell differentiation.INTRODUCTION
Gene expression during development is regulated at multiple
transcriptional and posttranscriptional levels, including control
of mRNA translation and degradation. Whereas a great deal is
known about the transcriptional regulatory networks that control
cell type specificity and differentiation, much less is understood
about the posttranscriptional regulatory circuits that are essen-
tial for mammalian development, particularly somatic cell dif-
ferentiation. Here, we use terminal erythropoiesis as a system
to explore posttranscriptional events that control an important
terminal cell differentiation pathway.
During the final stage of erythropoiesis, the erythropoietin
(Epo)-responsive erythroid (colony-forming unit erythroid;
CFU-E) progenitors undergo dramatic changes in morphology
and in protein expression. In the presence of Epo, CFU-Es
divide four to five times and undergo dramatic decreases in
both nuclear and cell sizes; chromatin condensation; hemoglo-
binization; and, ultimately, extrusion of the nuclei, forming
enucleated reticulocytes. These changes are accompanied by
significant transcriptome reprogramming; 600 genes are660 Developmental Cell 30, 660–672, September 29, 2014 ª2014 Elsinduced, and 6,000 genes are repressed at the RNA level dur-
ing terminal erythroid differentiation (Wong et al., 2011). These
transcriptomic changes are mediated by several key erythroid-
important transcription factors, including Gata1, Tal1, and
EKLF, as well as by the Epo-Epo receptor Jak2-Stat5 signaling
pathway (Hattangadi et al., 2011; Kerenyi and Orkin, 2010).
Much less is known concerning posttranscriptional regulation
of gene expression.
Here, we used primary mouse fetal liver cells to explore the
posttranscriptional regulatory events in terminal erythroid differ-
entiation. From embryonic days 12 to 16 (E12 to E16), mouse
fetal liver is the primary site of erythropoiesis. Most (90%) fetal
liver cells are in the erythroid lineage, providing us with a rela-
tively pure source of erythroid cells. Erythroid cells at different
developmental stages (erythroid burst-forming units [BFU-Es],
CFU-Es, and mature Ter119+ cells) can be purified using
different combinations of cell surface markers (Flygare et al.,
2011). Cultured late erythroid progenitor cells, predominantly
CFU-Es, undergo terminal proliferation and differentiation into
enucleated reticulocytes in vitro in a fashion that recapitulates
terminal erythropoiesis in vivo (Ji et al., 2008; Zhang et al.,
2003). Critically, transcriptomes, chromatin modifications, and
genomic occupancies by erythroid important transcription fac-
tors have been well documented in mouse fetal liver erythroid
cells at different stages of differentiation (Alvarez-Dominguez
et al., 2014; Pilon et al., 2011; Wong et al., 2011). These methods
and resources make terminal differentiation of mouse fetal liver
erythroid progenitors an ideal system to investigate the interrela-
tionships between transcriptional and posttranscriptional regu-
latory circuits in mammalian cell development.
Using genomic approaches, we identified a sequence-spe-
cific RNA-binding protein (RBP), Cpeb4, which is dramatically
induced in terminal erythroid differentiation by two erythroid
important transcription factors, Gata1 and Tal1. Cpeb4 belongs
to the cytoplasmic polyadenylation element binding (CPEB) pro-
tein family that, in mammals, has four members, Cpeb1–Cpeb4.
All CPEB proteins in mammals have RNA-binding domains in
their carboxyl termini that are responsible for binding to their
substrate mRNAs via recognition of specific sequences in the
30 untranslated region (30 UTR) (Ferna´ndez-Miranda and Me´n-
dez, 2012; Huang et al., 2006). Mechanistically, CPEB proteins
are best characterized as translational activators through elon-
gating poly(A) tails of target mRNAs via recruiting cytoplasmic
poly(A) polymerases, although CPEB proteins can also repress
translation (D’Ambrogio et al., 2013; Ferna´ndez-Miranda and
Me´ndez, 2012). Functionally, despite involvement in manyevier Inc.
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Figure 1. Cpeb4 Is Specifically Induced in
Terminal Erythroid Differentiation
(A) E14mouse fetal liver cells were fractionated into
R1–R5 based on the cell surface markers CD71
and Ter119.
(B) Cpeb4 mRNA was quantified in R1–R5 cells.
(C) Lin cells isolated from E14.5 mouse fetal liver
were cultured in erythroid differentiation media,
and Cpeb4 protein levels were determined by
western blot at each indicated time point. The ar-
row indicates CPEB4 protein, and the upper band
(#) is a nonspecific band.
(D) Different lineages of terminal differentiated he-
matopoietic cells and progenitor cells (Lin) were
isolated by magnetic assisted sorting from E14.5
mouse fetal liver followed by Cpeb4 mRNA quan-
tification (mean ± SD; n = 3; *p < 0.01 using two-
tailed Student’s t test).
(E) The RNA-seq data of erythroid cells at different
developmental stages and the ChIP-seq data sets
from mouse fetal liver Ter119+ cells at the Cpeb4
genomic region.
See also Figures S1 and S2.
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Translational Control Regulates Erythropoiesisbiological processes (e.g., embryo development, neuronal activ-
ity, cancer) (D’Ambrogio et al., 2013; Ferna´ndez-Miranda and
Me´ndez, 2012), CPEB proteins’ roles in somatic cell differentia-
tion still remain to be explored.
Here, we show that Cpeb4 is induced by the erythroid
important transcription factors Gata1 and Tal1, is strongly up-
regulated during terminal erythroid development, and is essen-
tial for terminal erythropoiesis. By binding directly to the trans-
lation initiation factor eIF3 complex, Cpeb4 represses the
translation of a large set of mRNAs, most of which are normally
downregulated during terminal erythroid development. Cpeb4
also binds to its own mRNA to repress its translation, and
ectopic expression of Cpeb4 blocks erythroid differentiation.
Thus, transcriptional induction and translational repression
combine to form a negative feedback loop to control Cpeb4
protein levels within a specific range that is required for termi-
nal erythropoiesis. Our study provides an example of how
translational control is integrated with transcriptional regulation
to precisely control gene expression during mammalian cell
differentiation.Developmental Cell 30, 660–672, SeRESULTS
Identification of RBPs Enriched
in Terminal Differentiating
Erythroblasts
RBPs play important roles in posttran-
scriptional regulation of gene expression.
It is interesting that ENCODE expression
profiles revealed that mammalian RBPs
are differentially expressed among dif-
ferent cells and tissues and that many
RBPs are highly cell type specific (Fig-
ure S1A available online) (Stamatoyanno-
poulos et al., 2012). These expression
patterns suggest that some RBPs are
required for formation of specific celltypes but that the roles of most RBPs in mammalian cell differen-
tiation are unknown. From the ENCODE data, we identified 49
RBPs that are enriched in fetal liver erythroblasts. Among these
49 RBPs, six are highly induced during terminal erythroid differ-
entiation from the CFU-E stage (Figure S1B). Here, we focused
on Cpeb4 because it is highly expressed in terminal differenti-
ating erythroblasts and is dramatically induced during terminal
differentiation. Among the four family members of CPEB pro-
teins, only Cpeb4 is highly expressed in mouse fetal liver termi-
nally differentiating erythroblasts (Figure S1C), allowing us to
specifically characterize the function of this protein in erythroid
development.
During Terminal Erythropoiesis, Cpeb4 Is Dramatically
Induced by Gata1 and Tal1
To determine the expression pattern of Cpeb4 in erythropoiesis,
we first fractionated total E14 mouse fetal liver into five popula-
tions (R1–R5) using the cell surfacemarkers CD71 (transferrin re-
ceptor) and Ter119 (glycophorin) (Figure 1A). R1 and R2 fractions
are enriched for erythroid progenitors, and R3–R5 containptember 29, 2014 ª2014 Elsevier Inc. 661
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Figure 2. Cpeb4 Is Required for Terminal
Erythroid Differentiation
(A) Cpeb4 mRNA and Cpeb4 and Gapdh protein
levels in shRNA knockdown cells and the shRNA
control cells. The arrow indicates Cpeb4 protein,
and # indicates a nonspecific band.
(B) Growth curves of Cpeb4 knockdown cells
and the shRNA control cells in the differentiation
medium.
(C) Measurement of the number of cell divisions at
24 hr and 48 hr in the differentiation medium.
(D and E) The cell cycle profiles of Cpeb4 knock-
down cells and the shRNA control cells.
(F and G) Apoptotic status of Cpeb4 knockdown
cells and the shRNA control cells wasmeasured by
annexin-V staining.
(H and I) Quantification of genes induced and
repressed in terminal erythroid differentiation by
real-time PCR. All the results are from three inde-
pendent measurements and presented as mean ±
SD. *p < 0.01 compared to the corresponding
control (two-tailed Student’s t test).
See also Figure S3.
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Translational Control Regulates Erythropoiesissuccessively differentiated erythroblasts, with R5 containing
mostly enucleated reticulocytes (Zhang et al., 2003). Real-time
PCR revealed that Cpeb4 mRNA is dramatically induced during
the transition from R2 to R3 (Figure 1B), congruent with the
period whenmost of the600 erythroid-important genes are up-
regulated (Wong et al., 2011). In our erythroid culture system
(Zhang et al., 2003), Cpeb4 protein levels peak at 24 hr (Fig-
ure 1C), correlating well with the induction of Cpeb4 mRNA
and the appearance of hemoglobinized erythroblasts (Ji et al.,
2008; Zhang et al., 2003). Collectively, these results indicate
that Cpeb4 mRNA and protein are dramatically induced during
terminal erythropoiesis.
To further determine whether Cpeb4 is specific to erythroid
cells, we fractionated total mouse fetal liver cells into different
cell lineages and progenitors using cell surface markers and
then quantified the Cpeb4 mRNA level using real-time PCR.
Clearly, Cpeb4 is highly enriched in terminal differentiating eryth-
roblasts (Ter119+) compared to other cell types (Figure 1D).
Two lines of evidence indicated that Cpeb4 mRNA is induced
byGata1 and Tal1, two erythroid-important transcription factors.662 Developmental Cell 30, 660–672, September 29, 2014 ª2014 Elsevier Inc.First, in published ChIP-seq (chromatin
immunoprecipitation with high-through-
put DNA sequencing) data sets from
primary mouse fetal liver erythroblasts
(Wong et al., 2011; Wu et al., 2011), there
are several discrete Gata1/Tal1 binding
signals within 40 kb of the Cpeb4 tran-
scription start site (Figure 1E). It is inter-
esting that these Gata1/Tal1 occupancy
sites correlate well with the transcription
enhancer marker H3K4me1 (Figure 1E),
suggesting that Cpeb4 expression is
regulated by Gata1 and Tal1. Second,
Gata1 activation in G1E cells is a well-es-
tablishedmodel for studying Gata1-medi-
ated regulation in erythropoiesis (Weisset al., 1997); in this system, Gata1 binding to theCpeb4 enhancer
regions is temporally congruent with transcriptional activation of
Cpeb4 (Figure S2). Together, these observations indicate that
Cpeb4 is a target of Gata1/Tal1 in terminal erythropoiesis.
Cpeb4 Is Required for Terminal Erythropoiesis
Small hairpin RNA (shRNA)-mediated loss-of-function studies
revealed that Cpeb4 is required for terminal erythroid differenti-
ation. Specifically, two shRNAs targeting different regions of
Cpeb4 were introduced into lineage-negative (Lin) cells via
retroviral transduction. Most of these Lin cells are CFU-Es (Fly-
gare et al., 2011). The transduced cells were first cultured in the
maintenance medium for 24 hr to allow shRNA expression and
then switched to differentiation medium. Both shRNAs efficiently
knock down both Cpeb4 mRNA and protein levels in differenti-
ating erythroblasts, as compared to a scrambled shRNA control
(Figure 2A).
Inhibition of Cpeb4 expression caused a marked inhibition of
terminal cell proliferation, as determined by counting the
numbers of live cells (Figure 2B). To quantify the number of cell
Developmental Cell
Translational Control Regulates Erythropoiesisdivisions in Cpeb4 knockdown cells, we labeled cell membranes
with an inert fluorescence dye and then used flow cytometry to
determine the fluorescence intensity of the labeled cells at
24 hr and 48 hr in the differentiation medium. During each cell di-
vision, the fluorescence dye is diluted by half; thus, by comparing
the fluorescence intensity at each time point to the original fluo-
rescence intensity, we can calculate how many cell divisions
have occurred. Clearly, the number of cell divisions in the
Cpeb4 knockdown cells is significantly reduced (Figure 2C), sug-
gesting that cell cycle progression is compromised. To specif-
ically examine the cell cycle, we pulse-labeled differentiating
erythroblasts with a reactive deoxynucleotide analog (5-ethynyl
20-deoxyuridine; EdU) to label S-phase cells and used a DNA
dye to discriminate the cells in the G1 and G2/M phases (Fig-
ure 2D). Knockdown of Cpeb4 caused cells to accumulate in
the G1 phase, accompanied by a dramatic decrease in the
numbers of S-phase cells (Figures 2D and 2E), indicating that
cell proliferation was severely compromised. In addition, there
was a large increase of apoptotic cells (annexin-V positive)
following Cpeb4 knockdown (Figures 2F and 2G). Collectively,
these results indicated that Cpeb4 is required for proper cell cy-
cle progression in terminal differentiating erythroblasts.
To further determine the changes of gene expression and the
downstream differentiation process in Cpeb4 knockdown
erythroid cells, we used real-time PCR to quantify the expression
of a group of erythroid-important genes induced during terminal
differentiation. Induction of these genes was blocked following
Cpeb4 knockdown (Figure 2H). Concomitantly, Cpeb4 knock-
down cells contained levels of key mRNAs normally downregu-
lated during terminal differentiation that were much higher than
normal (Figure 2I). These results revealed that terminal erythroid
differentiation in Cpeb4 knockdown cells was compromised.
To directly assay the products of terminal erythropoiesis, we
measured the generation of enucleated reticulocytes by using
a DNA dye to fractionate the cells with nuclei and the enucleated
cells. Simultaneously, the maturation of terminal differentiating
erythroblasts was monitored by Ter119 and CD71 staining.
When Cpeb4 was inhibited, the generation of enucleated reticu-
locytes was dramatically inhibited (Figures 3A and 3C). In addi-
tion, the maturation of differentiating erythroblasts, as indicated
by the CD71 and Ter119 double position cell population, was
also severely compromised (Figures 3B and 3C). Collectively,
these results indicate that induction of Cpeb4 is required for
terminal erythroid differentiation.
We believe that these phenotypes do not result from nonspe-
cific effects of the Cpeb4 shRNAs, and thus are specific to
Cpeb4, because the severity of all these phenotypes correlates
well with the Cpeb4 knockdown efficiencies (Figure 2). Further-
more, when the same two shRNAs were introduced into NIH
3T3-L1 cells, where Cpeb4 is not expressed, no phenotypic
changes in the cells were observed (Figure S3).
Cpeb4 Interacts with eIF3 to Repress mRNA Translation
in Erythroid Cells
CPEB proteins can both repress and activate target mRNA
translation (Ferna´ndez-Miranda and Me´ndez, 2012). To deter-
mine how Cpeb4 regulates gene expression in erythroid cells,
we used a tethering assay (Coller and Wickens, 2007). Using
the strong and specific interaction between the bacteriophageDevelopmenlN polypeptide and the BoxB RNA motif, we tethered the lN-
Cpeb4 fusion protein to the 30 UTR of a firefly luciferase reporter
mRNA (Figure 4A). The translatability of the reporter, defined as
luciferase activity normalized to luciferase mRNA level, was as-
sayed in erythroleukemia cells (K562 cells). It is interesting that
tethering Cpeb4 significantly reduced the reporter’s translat-
ability compared to tethering a green fluorescence protein
(GFP) to the 30 UTR of the reporter mRNA (Figure 4A). In addition,
there was no change in the luciferase reporter mRNA level
(Figure S4A) when Cpeb4 or GFP was tethered, indicating that
the effect was predominantly accomplished by translational
inhibition. It is important to note that translational repression
was dependent on the BoxB sites, since there was no change
in the translatability of the control reporter lacking these sites
when the lN-Cpeb4 fusion protein was introduced (Fig-
ure 4A).This observation indicates that inhibition of translatability
requires the binding of Cpeb4 to the reporter mRNA. These re-
sults revealed that Cpeb4 is a translation repressor in erythroid
cells; consistent with this notion, the two cytoplasmic poly(A)
polymerases, Gld2 and Gld4, which are required for CPEB pro-
tein-mediated translational activation (D’Ambrogio et al., 2013),
are not expressed in terminally differentiating erythroblasts
(Figure S4B).
To identify the proteins that interact with Cpeb4 in erythroid
cells, we performed affinity purification followed by mass spec-
trometry. Specifically, we immunoprecipitated both endogenous
Cpeb4 from primary mouse fetal liver erythroblasts and an
epitope-tagged Cpeb4 expressed in K562 cells. This experiment
was performed in the presence and absence of ribonuclease A
(RNase A) to discriminate RNA-independent and RNA-mediated
interactions. In both types of cells, mass spectrometry analyses
identified several eIF3 subunits as the major translation factors
that directly associate with Cpeb4 (Figures S4D and S4E; Table
S1). Notably, Maskin (Tacc3 in mouse) and eIF4E, which are
used by Cpeb1 in Xenopus oocytes to repress mRNA translation
(D’Ambrogio et al., 2013), were not detected, suggesting that
Cpeb4 uses a different mechanism to repress mRNA translation
in erythroid cells.
The eIF3 complex is the largest and the most complicated
translation initiation factor inmammals, with 13 nonidentical sub-
units (eIF3a to eIF3m) that can regulate translation initiation at
multiple steps (Hinnebusch, 2006, 2014; Sonenberg and Hinne-
busch, 2009). The several eIF3 subunits (eIF3a, eIF3b, eIF3c,
eIF3l) identified in our mass spectrometry analysis suggested
that Cpeb4 directly associates with the eIF3 complex in erythroid
cells. To further confirm this interaction, we used an antibody
against eIF3a subunit to immunoprecipitate the endogenous
eIF3 complex from primary mouse fetal liver erythroblasts (Fig-
ure 4B). Indeed, a different eIF3 subunit, eIF3b, was found to
coimmunoprecipitate with eIF3a (Figure 4B), indicating that this
approach can isolate the eIF3 complex (or part of the eIF3 com-
plex). Western blot analysis revealed that Cpeb4 specifically
coimmunoprecipitated with the eIF3 complex and that this inter-
action is independent of RNA (Figure 4B), indicating that Cpeb4
directly interacts with the eIF3 complex.
We hypothesized that, since Cpeb4 interacts with a general
translation initiation factor, if expressed at a high level, Cpeb4
may repress global mRNA translation in erythroid cells. To test
this, we created a mouse erythroleukemia (MEL) cell line thattal Cell 30, 660–672, September 29, 2014 ª2014 Elsevier Inc. 663
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Figure 3. Cpeb4 Knockdown Blocks the Generation of Enucleated Reticulocytes
(A) The generation of enucleated reticulocytes was analyzed in the Cpeb4 knockdown cells and the shRNA control cells. Staining was with Ter119 and the
Hoechst DNA-binding dye.
(B) The expression of cell surface markers Ter119 and CD71 was analyzed in Cpeb4 knockdown cells and the shRNA control cells.
(C and D) Quantifications of relative efficiencies of enucleation (C) and the percentages of Ter119 and CD71 double positive cells (D) in the Cpeb4 knockdown
cells and the shRNA control cells. All the results are from three independent measurements and presented as mean ± SD. *p < 0.01 using two-tailed Student’s
t test.
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Figure 4. Cpeb4 Represses mRNA Transla-
tion in Erythroid Cells by Interacting with
eIF3
(A) The translatability of the reporters in the pres-
ence and absence of lN-Cpeb4 was determined
by luciferase assay in K562 cells.
(B) Co-IP of endogenous eIF3 complex was per-
formed in mouse fetal liver Ter119+ cells, followed
by SDS-PAGE and western blotting to detect the
proteins as indicated. ^ indicates a nonspecific
band; # is likely to be degradation product(s) from
eIF3A.
(C) Quantification of Cpeb4 mRNA and protein
levels in MEL cells transduced by a Cpeb4-ex-
pressing retrovirus and control retrovirus.
(D and E) The polyribosome profiles (D) and the
translation rates (E) of Cpeb4-expressing MEL
cells were compared to those of the control cells.
(F and G) IRES-based bicistronic luciferase re-
porters (F) were transfected into K562 cells, and
then luciferase assays were performed in the
presence and absence of ectopic expression of
Cpeb4 to measure the translation status of these
reporters. All the results are from three indepen-
dent measurements and presented as mean ± SD.
*p < 0.01, and n.s. indicates p > 0.05, using two-
tailed Student’s t test.
See also Figure S4 and Table S1.
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Translational Control Regulates Erythropoiesisoverexpresses Cpeb4 (Figure 4C). We first examined global
mRNA-ribosome associations by sucrose-gradient-mediated
polyribosome profiling (Figure 4D). It is interesting that Cpeb4
overexpression resulted in an obvious decrease of polyribo-
somes with a corresponding increase of 80S ribosomes (Fig-
ure 4D), indicating an inhibition of translation initiation. Notably,
overexpression just of the C-terminal segment of Cpeb4, which
contains all of the RNA-binding domains (Huang et al., 2006),
does not influence global mRNA-ribosome association (Fig-
ure S4C). This indicates that Cpeb4-mediated translation inhibi-
tion is not caused by general RNA binding. To directly measure
the global translation rate, we pulse-labeled cells with a nonra-
dioactive methionine analog and measured how fast it can be
incorporated into polypeptides in the MEL cells. We found that
Cpeb4 overexpression reduced the global translation rate to
80% of that in the control cells (Figure 4E). The different extents
of translation inhibition we observed from polyribosome profiling
and the methionine incorporation assay are probably due to
the different aspects of translation these two assays measure:Developmental Cell 30, 660–672, SemRNA-ribosome binding in the polysome
profile versus translation kinetics in the
methionine incorporation assay. None-
theless, these results indicate that
Cpeb4 can repress mRNA translation in
erythroid cells and suggest that the
Cpeb4-eIF3 interaction is functional.
We next showed that Cpeb4-mediated
translation repression requires the eIF3
complex by using an assay that measures
translation from an internal ribosome en-
try site (IRES). IRES elements are struc-
tured RNAs that are usually encoded byviral genomes to position and activate eukaryotic translational
initiation (Fraser and Doudna, 2007). It is important to note that
different viral IRES elements require different sets of translation
factors (Fraser and Doudna, 2007). To study Cpeb4-mediated
translation repression, we used the eIF3-dependent HCV IRES
and the eIF3-independent CrPV IRES (Fraser and Doudna,
2007). Specifically, a bicistronic reporter was used in which
firefly luciferase (Fluc) is translated by cap-dependent translation
and translation of renilla luciferase (Rluc) is controlled either by
hepatitis C virus (HCV)-IRES-mediated or cricket paralysis virus
(CrPV)-IRES-mediated translation (Figure 4F). When these two
reporters were transfected into K562 cells (human erythroleuke-
mia cells), as expected, cap-dependent translation from both re-
porters was repressed following Cpeb4 expression (Figure 4G),
as determined by the Fluc activity. However, Cpeb4 only
repressed HCV-IRES-mediated translation but did not affect
CrPV-IRES-mediated translation (Figure 4G). Since HCV-IRES
requires the eIF3 complex to initiate translation while CrPV-
IRES does not, these results revealed that Cpeb4-mediatedptember 29, 2014 ª2014 Elsevier Inc. 665
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Figure 5. Cpeb4 Represses Target mRNA
Translation in Differentiating Erythroblasts
(A and B) The 30 UTRs from Cpeb4 RIP-enriched
mRNAs were compared to those from depleted
mRNAs to determine the enrichment of known
CPEs (A), and then eight-nucleotide motifs in the 30
UTRs from the enriched mRNAs were compared to
randomly selected mRNAs to identify the most
overrepresented motifs in the mRNAs associated
with Cpeb4 (B).
(C and D) RIP followed by real-time PCR was used
to verify 16 Cpeb4-associatedmRNAs (C), and then
gene ontology analysis was performed on all the
Cpeb4-assocaited transcripts identified from the
Cpeb4 RIP-Chip (D).
(E) The polyribosome profiles of Cpeb4-over-
expressing MEL cells and control cells.
(F) The distribution of two Cpeb4 target mRNAs, the
endogenousCpeb4mRNA, andCdk6mRNA, and a
control mRNA on a sucrose-density gradient from
MEL cells was determined by real-time PCR in the
presence and absence of Cpeb4. All the results are
from three independent measurements and pre-
sented as mean ± SD. *p < 0.01, using two-tailed
Student’s t test.
See also Figure S5 and Table S2.
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Translational Control Regulates Erythropoiesistranslation repression is dependent on eIF3, indicating that
the repressive Cpeb4-eIF3 interaction is operative in erythroid
cells.
Collectively, these experiments revealed that Cpeb4 is a trans-
lation repressor in erythroid cells; it interacts with the generation
translation initiation factor eIF3, and this interaction is function-
ally relevant for Cpeb4-mediated translation repression.
Cpeb4 Represses the Translation of a Set of mRNAs,
Including Its OwnmRNA, during Terminal Erythropoiesis
To identify the endogenous mRNA substrates that Cpeb4 regu-
lates, we performed RNA immunoprecipitation (RIP) followed by
microarray (RIP-Chip) studies targeting endogenous Cpeb4 in
mouse primary fetal liver erythroblasts (Jain et al., 2011) (Gene
Expression Omnibus ID GSE57004). We used three criteria to
identify Cpeb4 substrate mRNAs from the microarray data. First,
the substrate mRNAs should be enriched at least 2.5-fold in the
RIP sample versus the input. Second, the substrate mRNAs
must have higher signal intensity in the RIP sample compared666 Developmental Cell 30, 660–672, September 29, 2014 ª2014 Elsevier Inc.to that in the immunoglobulin G (IgG) con-
trol. Third, the substrates should be repro-
ducibly detected in two independent
Cpeb4 RIPs. These criteria resulted in
227 putative Cpeb4 target transcripts (Ta-
ble S2).
Three lines of evidence indicate that
the 227 mRNAs identified by RIP-Chip
are Cpeb4 substrates in differentiating
erythroblasts. First, all of the five known
cytoplasmic polyadenylation elements to
which Cpeb4 can bind (Ortiz-Zapater
et al., 2012) were significantly enriched in
the 30 UTRs of the 227 enriched mRNAs,
compared to those of 503 control transcripts that were depleted
in the Cpeb4 RIP-Chip (Figure 5A). Second, a uridine-rich
(U-rich) eight-nucleotide motif was statistically overrepresented
in the 30 UTRs of the 227 enriched mRNAs compared to those
in randomly selected mRNAs (Figure 5B). Critically, this U-rich
motif resembles the consensus Cpeb4 binding sequences iden-
tified from in vitro binding studies (Huang et al., 2006; Ray et al.,
2013). Third, we selected 16 mRNAs from these 227 mRNAs for
experimental verification. RIP followed by real-time PCR re-
vealed that all 16 mRNAs were immunoprecipitated in significant
amounts by an anti-Cpeb4 antibody but not by the IgG control
(Figure 5C). It is important to note that Cpeb4 did not bind two
abundant control RNAs, Gapdh mRNA and 18S rRNA (Fig-
ure 5C), indicating that the Cpeb4-mRNA interaction is specific.
Collectively, these results indicated that the 227 mRNAs are
Cpeb4 substrates in differentiating erythroblasts. Gene ontology
analysis indicated that Cpeb4 substrates are enriched for
mRNAs encoding protein kinases, nucleic acid helicases, chro-
matin modifiers, and ubiquitin-domain-containing proteins
Developmental Cell
Translational Control Regulates Erythropoiesis(Figure 5D), suggesting that Cpeb4 can modulate expression of
these factors in differentiating erythroblasts.
To determine the functional consequence of Cpeb4 binding to
the target mRNAs, we analyzed the distribution of Cpeb4 target
mRNAs in MEL cells across a polyribosome gradient in both the
presence and the absence of Cpeb4 expression (Figure 5E).
When Cpeb4 was expressed, both endogenous Cpeb4 mRNA,
as determined by real-time PCR targeting the 30 UTR, and
Cdk6 mRNA shifted from the polyribosome to the 80S region
(Figure 5F), indicating translation inhibition of these two Cpeb4
substrate mRNAs. Notably, Cpeb4 expression did not change
the distribution of Gapdh mRNA on the gradient (Figure 5F),
indicating the specificity of Cpeb4-mediated translational re-
pression. These results indicated that Cpeb4 binding results in
translational inhibition of multiple substrate mRNAs.
Two lines of observations indicated that inhibiting the expres-
sion of Cpeb4 substrate mRNAs is important for terminal eryth-
ropoiesis. First, downregulation of Cdk6 is known to be required
for terminal erythroid differentiation, while constitutive expres-
sion of Cdk6 blocks this differentiation process (Matushansky
et al., 2000, 2003). Since Cdk6mRNA is translationally repressed
by Cpeb4 in terminal differentiating erythroblasts, these results
partially explain why Cpeb4-mediated translation repression is
important for terminal erythropoiesis.
Second, we constitutively expressed seven Cpeb4 substrate
mRNAs, including Cdk6 mRNA, in primary fetal liver erythro-
blasts and then assayed terminal erythroid differentiation by
monitoring the formation of enucleated reticulocytes. We found
that constitutive expression of each of these Cpeb4 substrates
blocks terminal erythroid differentiation (Figures S5A and S5B).
Notably, constitutive expression of a control protein, Rluc, had
no effect on this differentiation process (Figures S5A and S5B).
These results suggest that downregulation of theseCpeb4 target
genes is functionally important for terminal erythropoiesis. It is
interesting that the levels of most of the 227 Cpeb4 substrate
mRNAs decrease monotonically during terminal erythroid differ-
entiation (Figure S5C), suggesting that Cpeb4-mediated transla-
tion repression further ensures that the proteins encoded by
these mRNAs are not produced in terminally differentiating
erythroblasts.
Maintaining Cpeb4 Protein Level within a Specific
Range Is Required for Terminal Erythropoiesis
One striking finding is that Cpeb4 can bind to a large amount of its
own mRNA (Figure 5C), suggesting that Cpeb4-mediated nega-
tive translational regulation functions in a circuit with Gata1/
Tal1-mediated transcriptional induction to control Cpeb4 protein
levels within a specific range during terminal erythropoiesis. Our
loss-of-function studies indicated that decreasing Cpeb4 protein
levels below this range is detrimental to terminal erythropoiesis
(Figures 2 and 3). To further test the functional importance of
maintaining Cpeb4 protein levels within a specific range, we
used retroviral transduction to constitutively express Cpeb4 dur-
ing terminal erythropoiesis, increasing both Cpeb4 mRNA and
protein above their normal levels in differentiating erythroblasts
(Figures 6A and 6B). This resulted in a phenotype very similar to
that of Cpeb4 knockdown, as indicated by inhibition of cell prolif-
eration (Figure 6C) and cell division (Figure 6D), disappearance of
cells in the S phase (Figures 6E and 6F), increase of apoptoticDevelopmencells (Figures 6G and 6H), and inability to form enucleated retic-
ulocytes (Figures 6I and 6J). It is important to note that constitu-
tive expression of only the C-terminal segment of Cpeb4 that
contains all the RNA-binding domains (Huang et al., 2006) does
not affect terminal erythroid differentiation, as indicated by the
generation of enucleated reticulocytes (Figures S6A–S6C). This
indicates that the phenotypes we observed following Cpeb4
constitutive expression are not caused by general RNA binding.
In addition, these phenotypes are specific to Cpeb4, because
constitutive expression of another mRNA-binding protein,
Carhsp1, which is also dramatically induced during terminal
erythropoiesis (Figure S1B), did not inhibit terminal erythroid dif-
ferentiation (Figures S6D–S6F). Collectively, these observations
revealed that maintaining Cpeb4 protein levels within a specific
range is important for terminal erythropoiesis.
Cpeb4 Is Functionally Important In Vivo
To explore the in vivo functional significance of Cpeb4, we ob-
tained a Cpeb4 heterozygous mouse from the International
Knockout Mouse Consortium. The mouse was constructed by
inserting after the first exon of Cpeb4 a reporter-tagged
sequence that contains a strong transcriptional termination
signal (pA signal) (Figure 7A) (Skarnes et al., 2011). We verified
the genotype of the knockout mouse by PCR (Figure 7B) and
showed by western blotting that the level of Cpeb4 protein in ho-
mozygous knockout E14.5 fetal liver cells is below the detection
limit (Figure 7C). In breeding Cpeb4 heterozygous mice, wild-
type, heterozygous, and homozygous embryos were present at
E14.5–E15.5 in the expected Mendelian ratio (Figure 7D). How-
ever, of the 364 mice resulting frommatings of the heterozygous
Cpeb4 mice we genotyped at 2–3 weeks of age, only 5 were
Cpeb4 homozygotes (Figure 7E), while wild-type and Cpeb4 het-
erozygous mice were born in the predicted Mendelian ratio.
Thus, Cpeb4 homozygous mice die in utero after E15 or within
2 weeks of birth, strongly arguing that Cpeb4 is required for
normal development in vivo.
Two lines of evidence indicate that terminal erythropoiesis is
impaired in the Cpeb4 knockout embryo, which may contribute
to the death phenotype. First, Cpeb4 homozygous knockout
E14.5 fetal liver has significantly fewer terminally differentiating
Ter119+ erythroblasts compared to those of wild-type and the
heterozygous embryos (Figure 7F). Second, during terminal dif-
ferentiation, Ter119+ erythroblasts cells gradually lose the trans-
ferrin receptor (CD71); thus the relative level of CD71 on Ter119+
cells is a measure of their progression during differentiation.
We found that E14.5 Cpeb4 / Ter119+ cells express higher
levels of CD71 compared to Cpeb4+/ and wild-type Ter119+
cells (Figures 7G and 7H), indicating that the differentiation is
compromised. Collectively, these observations reveal that a
deficiency of Cpeb4 in vivo causes a block in terminal erythroid
differentiation.
DISCUSSION
Here, we characterized a Cpeb4-mediated negative translational
regulatory circuit that is required for terminal erythropoiesis. This
translational regulatory circuit is transcriptionally induced by
Gata1/Tal1 and is translationally negatively autoregulated by
Cpeb4 itself. We argue that this regulatory circuit limits the leveltal Cell 30, 660–672, September 29, 2014 ª2014 Elsevier Inc. 667
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Figure 6. Constitutive Expression of Cpeb4
Inhibits Terminal Erythroid Differentiation
(A and B) The Cpeb4 mRNA (A) and protein (B) levels
in mouse primary fetal liver erythroblasts constitu-
tively expressing ectopic Cpeb4 and control cells.
The arrow indicates Cpeb4 protein, and # indicates a
nonspecific band.
(C) Growth curves of Cpeb4 constitutive expressing
cells and control cells in the differentiation medium.
(D) Measurement of the number of cell divisions at
24 hr and 48 hr in the differentiation medium.
(E and F) The cell cycle profiles of Cpeb4 constitutive
expressing cells and the control cells.
(G and H) Apoptotic status of Cpeb4 constitutive
expressing cells and the shRNA control cells was
measured by annexin-V staining.
(I and J) Enucleation of Cpeb4 constitutive ex-
pressing cells and the control cells. All the results are
from three independent measurements and pre-
sented as mean ± SD. *p < 0.01, using two-tailed
Student’s t test.
See also Figure S6.
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Translational Control Regulates Erythropoiesisof Cpeb4 expression to within a specific range required for this
cell differentiation process.
A previously reported Cpeb4 homozygous knockout mouse
was reported to be normal (Tsai et al., 2013), while our Cpeb4 ho-
mozygous knockout mouse has a clear late embryonic early
neonatal lethal phenotype. This phenotypic difference could
arise from different methods used to generate these knockout
mice. Specifically, our mouse contains a strong transcription
termination signal after the first exon of Cpeb4, thereby inhibiting
the generation of full-length Cpeb4 mRNA. In contrast, Tsai et al.
(2013) deleted exon 2 of Cpeb4, resulting in Cpeb4 transcripts
with premature stop codons (PTCs). Since truncated proteins
can be generated from the PTCs and potential translational read-
through at PTCs can generate the full-length protein (or longer
truncated proteins), the Cpeb4 allele that Tsai et al. (2013) gener-
ated may be hypomorphic, which can potentially explain the
negative results of their Cpeb4 knockout mouse. Our Cpeb4/
mice are lethal some time after E14.5 and before 2 weeks after668 Developmental Cell 30, 660–672, September 29, 2014 ª2014 Elsevier Inc.birth. Considering that Cpeb4 is expressed
in multiple tissues and cells (neurons, fetal
liver erythroblasts, etc.) and Cpeb4 has
been implicated in regulating meiosis and
mitotic cell-cycle progression (Igea and
Me´ndez, 2010; Novoa et al., 2010), we
speculate that the lethal phenotype we
observed may be due to defects in multiple
tissues. Nonetheless, the defects in termi-
nal erythropoeisis we observed at E14.5
indicate that Cpeb4 is indeed required for
proper terminal erythroid differentiation
in vivo and also suggest that these erythro-
poiesis defects contribute to the lethal
phenotype.
CPEB proteins are important transla-
tional regulators in diverse biological pro-
cesses (D’Ambrogio et al., 2013). Among
the four family members, Cpeb4 has beenimplicated in regulating neuronal activities, mitosis, meiosis,
and cancer metastasis (Huang et al., 2006; Igea and Me´ndez,
2010; Novoa et al., 2010; Ortiz-Zapater et al., 2012; Theis
et al., 2003). It is interesting that, under these biological settings,
Cpeb4 predominantly functions as a translational activator by re-
cruiting cytoplasmic poly(A) polymerase(s) to extend the poly(A)
tails on the 30 ends of target mRNAs. For example, Cpeb4 acti-
vates target mRNA translation in the activated oocyte and in
pancreatic tumors (Ortiz-Zapater et al., 2012). Here, however,
we found that, in terminal differentiating erythroblasts, the two
known cytoplasmic poly(A) polymerases are not expressed
and that Cpeb4 functions as a translation repressor. These ob-
servations are consistent with the notion that CPEB proteins
can both repress and activate mRNA translation.
Then what triggers the functional switch of Cpeb4 from a
translation activator to a repressor? We speculate that, under
different biological contexts, posttranslational modifications
and/or association with different protein complexes may
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Figure 7. Cpeb4 Is Functionally Important
In Vivo
(A) Structures of Cpeb4 genomic region in wild-
type and Cpeb4 knockout mouse. P1, P2, and P3
are PCR primers for genotyping.
(B) Genotyping of wild-type (+/+), Cpeb4 hetero-
zygous (+/), and Cpeb4 knockout (/) mice by
PCR.
(C) Western blot of E14.5 total fetal liver cells iso-
lated from wild-type, Cpeb4 heterozygous, and
Cpeb4 homozygous knockout embryos.
(D) Genotyping of E14.5–E15.5 embryos from a
mating of Cpeb4 heterozygotes.
(E) Genotyping of 2- to 3-week-old mice from
matings of Cpeb4 heterozygotes.
(F) The quantification of Ter119+ cells in fetal livers
from E14.5 embryos. The y axis is the scale relative
to a known amount of added beads. *p < 0.05,
using two-tailed Student’s t test.
(G) CD71 and Ter119 staining of total E14.5 fetal
liver cells.
(H) CD71 expression levels in Ter119+ cells from
E14.5 mouse fetal liver. The black arrow indicates
high CD71 level; the red arrow indicates low CD71
level.
The results of (G) and (H) are representative of
E14.5 embryos from four sets of matings of Cpeb4
heterozygotes.
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Translational Control Regulates Erythropoiesismediate this functional switch for Cpeb4. Such has been
observed for Cpeb1, the best characterized CPEB protein family
member. Specifically, in the Xenopus oocyte, phosphorylation of
Cpeb1 by the Aurora kinase results in disassociation of Cpeb1
from a translation repression complex and formation of a trans-
lation activation complex that recruits cytoplasmic polyadeny-
lases (D’Ambrogio et al., 2013; Ferna´ndez-Miranda andMe´ndez,
2012). Although Aurora kinase phosphorylation sites are absent
in Cpeb4 (Theis et al., 2003), it would be very interesting to
explore the posttranslational modification status of Cpeb4 and
the factors with which it associates in terminal erythroid cells,
as well as in other biological settings.
Mechanistically, we found that Cpeb4 interacts with the eIF3
complex to repress mRNA translation in erythroid cells. This is
different from the translational repression mechanism used by
Cpeb1. In the Xenopus oocyte, Cpeb1 interacts with Maskin to
interfere with eIF4E’s binding to the 50 end cap structure of
mRNA, thereby inhibiting translation initiation. Although Maskin
(Tacc3 in mouse) is abundantly expressed in erythroid cells,
we did not observe an interaction with Cpeb4 in our mass spec-
trometry analyses. In addition, Cpeb4 can inhibit certain IRES
(HCV)-mediated translational initiation, indicating that Cpeb4 in-
hibits translation at the step(s) after 50 end cap recognition.Developmental Cell 30, 660–672, SeThese results indicate that Cpeb4 uses a
previously uncharacterized mechanism
to repress translation. We believe that
eIF3 is important for Cpeb4-mediated
translation because Cpeb4 directly asso-
ciates with eIF3 complex. Furthermore,
Cpeb4 represses eIF3-dependent trans-
lation (cap-dependent translation and
HCV-IRES-mediated translation), but noteIF3-independent translation (CrPV-IRES-mediated translation).
These observations indicate that the Cpeb4-eIF3 interaction is
functional in translational repression. eIF3 is the most compli-
cated translation initiation factor, with 13 nonidentical subunits
in mammals that can regulate translation initiation at multiple
steps, including facilitation of 48S complex formation and recy-
cling of posttermination complexes (Hinnebusch, 2006, 2014;
Pisarev et al., 2007). Although we showed that Cpeb4 directly
associates with the eIF3 complex, our data do not indicate the
subunit(s) of eIF3 complex to which Cpeb4 directly binds.
Thus, it would be of great interest in the future to characterize
this Cpeb4-eIF3 interaction in detail, which will shed light into
the detailed molecular mechanisms of Cpeb4-mediated transla-
tion repression.
In terminal erythropoiesis, differentiating erythroblasts un-
dergo dramatic morphological changes that include chromatin
condensation, decrease of nuclei size, and eventually exit of
the cell cycle and extrusion of the nucleus, resulting in enucle-
ated reticulocytes. These morphological changes require coor-
dinated control of many factors involved in diverse cellular
processes. For example, many histone modifiers and transcrip-
tion activators that maintain active chromatin status need to be
inhibited prior to or during chromatin condensation, and cellptember 29, 2014 ª2014 Elsevier Inc. 669
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Translational Control Regulates Erythropoiesiscycle activators and DNA replication factors need to be downre-
gulated so that erythroid cells can exit the cell cycle. It is inter-
esting that many Cpeb4 substrate mRNAs encode proteins
involved in maintaining active chromatin structures (e.g., Mll1-3
and Med13) and controlling cell cycle and DNA replication
(e.g., Cdk6 and nucleic acid helicases). Thus, it is tempting to
speculate that Cpeb4 contributes to terminal erythropoiesis by
inhibiting the expression of those proteins that need to be down-
regulated during this terminal cell differentiation process. In
addition, we also observed that Cpeb4 binds a group of ubiqui-
tin-domain-containing proteins that have decreasing mRNA
levels in terminal erythroid differentiation. This observation sug-
gests that downregulation of these protein degradation regula-
tors may also be important for the generation of enucleated
reticulocytes.
As important translational regulators, CPEB proteins can
form autoregulatory loops to control their own expression. In
Drosophila oocytes, the Cpeb1 homolog, Orb, binds its own
mRNA to stimulate its translation, thereby forming a positive au-
toregulatory loop at the translational level to generate large
amount of Orb protein that is required for stimulating the transla-
tion of developmentally important mRNAs (Tan et al., 2001). In
contrast, in erythroid cells, we found that Cpeb4 also binds its
own mRNA but that, instead, Cpeb4 represses translation of
its own mRNA, thereby generating a negative autoregulatory
loop to limit Cpeb4 protein levels within a specific range in termi-
nal erythroblasts. Our functional studies indicate that this nega-
tive regulatory circuit is important for erythroid differentiation, as
disruption of this loop both by loss-of-function and gain-of-func-
tion approaches block this developmental process. We specu-
late that this negative autoregulation mechanism used by
Cpeb4 ensures that Cpeb4 protein will not accumulate to high
levels that may interfere with the translation of other mRNAs
that are important for forming enucleated reticulocytes (e.g., he-
moglobin mRNA translation). It is interesting that Cpeb4 mRNA
is also dramatically induced in human terminal erythropoiesis
(Merryweather-Clarke et al., 2011). In addition, there are multiple
U-rich motifs in the 30 UTRs from both mouse and human Cpeb4
mRNAs, some of which are conserved between these two spe-
cies. Thus, we speculate that Cpeb4-mediated translational reg-
ulatory circuit is conserved between mouse and human.
In summary, our study characterized a negative translational
regulatory circuit that is required for terminal erythropoiesis by in-
hibiting the translation of many genes normally downregulated
during terminal erythropoiesis. Notably, this translational regula-
tory circuit is induced by well-characterized transcriptional regu-
latory networks, precisely coupling translational and transcription
regulation to modulate the expression of multiple genes during
terminal erythroid differentiation. We speculate that similar post-
transcriptional regulatory circuits exist in other mammalian cell
differentiation processes.
EXPERIMENTAL PROCEDURES
Plasmids and Oligonucleotides
See Supplemental Experimental Procedures.
Mouse Strain and Fetal Liver Cell Analysis
All the mice used in this study were in a C57BL/6 background. The Cpeb4 het-
erozygous knockout mouse (C57BL/6NTac-Cpeb4tm1a(EUCOMM)Wtsi/Cnrm)670 Developmental Cell 30, 660–672, September 29, 2014 ª2014 Elswas imported from the International Knockout Mouse Consortium. All animal
experiments were in compliance with regulations established by the White-
head Institute veterinary staff. To determine the number of Ter119+ cells and
the expression of CD71 in E14.5 mouse fetal liver, the cells from a fetal liver
were dissociated and resuspended in 300 ml PBS. Cells (100 ml) were used
for staining with antibodies to Ter119 (allophycocyanin) and CD71 (fluorescein
isothiocyanate) as well as with propidium iodide. After staining, the cells were
washed and resuspended in 500 ml PBS. Then, 50 ml CountBright Absolute
Counting Beads (Life Technologies) (0.51 3 105 beads per milliliter) were
added as a standard for quantification of the cell number.
Tissue Culture and Retrovirus Transduction
Erythroid progenitor cells were isolated from E14.5 C57BL/6 mouse fetal liver
cells and then cultured in maintenance and differentiation medium using the
media and methods described elsewhere (Hu et al., 2011). A shRNA-express-
ingmurine stem cell virus retroviral vector was used for shRNA-mediated loss-
of-function studies (Hu et al., 2011); pRetroX-IRES-DsRedExpress vector
from Clontech was used for gain-of-function studies. All the retroviruses
were packaged in 293T cells via the pCL-eco packaging vector and then
used to transduce erythroid progenitor cells using the methods described
elsewhere (Hattangadi et al., 2010). K562 cells were obtained from the Amer-
ican Type Culture Collection, andMEL cells were a kind gift fromDr. Barry Paw
(Harvard Medical School).
RNA and Protein Analysis
The miRNeasy Mini Kit from QIAGEN was used to extract total RNA from cell
lines or primary cells isolated by fluorescence-activated or magnetic-assisted
cell sorting. In all RNA isolation procedures, DNase I on-column digestion
(QIAGEN) was performed to remove genomic DNA. Complementary DNA
from the isolated RNAs was synthesized using the Superscript II reverse tran-
scriptase (Invitrogen) with random primers. Real-time PCR was performed on
an ABI Prism 7900 sequence detection system using SYBRGreen PCRMaster
Mix (Applied Biosystems). Proteins from target cells were extracted by RIPA
buffer (50 mM Tris-HCl, pH 7.4, 1% NP-40, 0.5% Na-deoxycholate, 0.1%
SDS, 150 mM NaCl, 2 mM EDTA, 50 mM NaF). Then, SDS-PAGE and western
blot were used to detect target proteins using the following antibodies: Cpeb4
(Abcam: ab83009), Gapdh (Santa Cruz Biotechnology: sc-32233), eIF3A (Cell
Signaling: 2538), and eIF3B (Abcam: ab133601).
Flow Cytometry Analysis
The flow cytometry analyses were performed on a BD LSR II flow cytometer
(BD Biosciences). All the antibodies used for flow cytometry were from eBio-
sciences. Terminal erythroid differentiation and enucleation were analyzed
by the same methods as described elsewhere (Ji et al., 2008). Cell prolifera-
tion, cell division, cell cycle, and apoptosis were analyzed using the Count-
Bright Absolute Counting Beads (Life Technologies), the CellTrace CFSE
Cell Proliferation Kit (Life Technologies), Click-iT EdUPacific Blue FlowCytom-
etry Assay Kit (Life Technologies), and Annexin V Pacific Blue conjugate (Life
Technologies), respectively, in accordance with the corresponding protocols.
For the cell proliferation analysis, 10 mM CFSE (carboxyfluorescein diacetate
succinimidyl ester) dye was used to label cells for 10 min at 37C.
Polysome Analysis and Translation Rate Measurement
Polysome analysis was performed as described elsewhere (Hu et al., 2009). In
brief, 50 million MEL cells were lysed in polysome lysis buffer (10 mM Tris-HCl,
pH 7.4, 12 mM MgCl2, 100 mM KCl, 1% Triton X-100, 100 mg/ml cyclohexi-
mide). The cell lysate was loaded on to a 10%–50% (w/v) linear sucrose-den-
sity gradient and then centrifuged at 37,000 rpm in a SW-41Ti rotor for 2 hr at
4C. The gradient was then fractionated using a Gradient Station (BioComp)
coupled with a UV monitor (Bio-Rad EM-1). The RNA from each fraction was
isolated by the method described by Hu et al. (2009). The global translation
rate was measured by using the Click-iT HPG Alexa Fluor 594 protein synthe-
sis assay kit (Life Technologies).
Luciferase Assays
Luciferase assays were performed in accordance with the protocol from the
Dual-Luciferase Reporter Assay System (Promega). Specifically, reporters
and Cpeb4-expressing plasmids were transfected into K562 cells using theevier Inc.
Developmental Cell
Translational Control Regulates ErythropoiesisLipofectamine LTX reagent (Life Technologies), and then luciferase assays
were performed at 30 hr after transfection.
Affinity Purification and Immunoprecipitation
The Cpeb4 complex was purified from 50 million mouse fetal liver Ter119+
cells and 50 million K562 cells stably expressing Cpeb4-GFP using anti-
Cpeb4 and anti-GFP (abcam 290) antibodies, respectively. Antibody (10 mg)
was used for each purification, and the purification was performed in the pres-
ence and absence of RNase A (200 mg/ml) using a magnetic immunoprecipita-
tion (IP) and co-IP kit from Pierce (catalog no. 88805). The purified complex
was resolved on an SDS-PAGE gel, followed by silver staining using reagents
compatible with mass spectrometry (Pierce, catalog no. 24600). After silver
staining, each lane on the SDS-PAGE gel was cut into ten pieces for mass
spectrometry to identify proteins at the Biopolymers & Proteomics Lab at
the Koch Institute of MIT. Anti-eIF3A antibody (5 mg) was used to immunopre-
cipitate the eIF3 complex from 20 million mouse fetal liver Ter119+ cells. The
purified complex was then subject to SDS-PAGE followed by western blotting.
Bioinformatic Analysis
RIP-Chip data from Affymetrix Mouse Gene ST Arrays were normalized by
RMA (robust multiarray average) using the Affy package from Bioconductor.
A custom probe set definition was used for processing the arrays as defined
by Dai et al (2005) so that one probe set represents one Entrez Gene ID. The
microarray results were deposited at the Gene Expression Omnibus with
accession number GSE57004.
To identify Cpeb4 binding motifs, refGene 30 UTR sequences were down-
loaded from the University of California, Santa Cruz, Table Browser in January
2014, with repeat sequences masked to N. For each gene, all the possible
distinct 8-mers were identified with the word count function in EMBOSS
(Rice et al., 2000). Fisher’s exact test was used to identify enriched 8-mers in
the Cpeb4-enriched mRNAs relative to either the depleted mRNAs in the
Cpeb4 RIP-Chip or a background set of 17,791 coding genes in both RNA
sequencing and RIP-Chip excluding the Cpeb4-enriched mRNAs. To identify
motifs in the 227 enriched mRNAs in the Cpeb4 RIP-Chip, we randomly
selected the same number of enriched mRNAs from the 17,791 background
genes 1,000 times. Each time, we ran Fisher’s exact test and looked for the
overrepresented 8-mer motifs (false-discovery-rate-corrected p < 0.05) in the
Cpeb4 bound mRNAs. Only the enriched motifs in all 1,000 replicates were
used to draw the sequence logo with WebLogo (http://weblogo.berkeley.edu).
The gene ontology analysis was performed using the DAVID Functional
Annotation BioinformaticsMicroarray Analysis (http://david.abcc.ncifcrf.gov/).
Statistical Analysis
Two-tailed Student’s t test was used to determine whether two sets of data are
statistically different from each other. All statistical analyses and the resulting
graphs were performed and generated using GraphPad Prism version 6. Data
are presented as mean ± SD.
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